GOAL Canada: Physician Education and Support Can Improve Patient Management-Reference-Cited by-同舟云学术

GOAL Canada: Physician Education and Support Can Improve Patient Management

Published:2020-03 Issue:2 Volume:2 Page:49-54
ISSN:2589-790X
Container-title:CJC Open
language:en
Short-container-title:CJC Open

Author:

Langer Anatoly,Tan Mary^ORCID,Goodman Shaun G.,Grégoire Jean,Lin Peter J.,Mancini G. B. John,Stone James A.,Wills Cheryll,Spindler Caroline^ORCID,Leiter Lawrence A.

Funder

Amgen

Bayer

BMS

Merck

Novo Nordisk

Pfizer

Servier

Sanofi

AstraZeneca

The Medicines Company

Boehringer Ingelheim

Bristol-Myers Squibb

Lilly

Ferring Pharmaceuticals

Johnson & Johnson

Novartis

Sunovion

CSL Behring

Daiichi-Sankyo

GlaxoSmithKline

Regeneron

Heart and Stroke Foundation

University of Toronto

Duke Clinical Research Institute

New York University

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins;Baigent;Lancet,2005

2. The Lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low density lipoprotein cholesterol goals;Pearson;Arch Intern Med,2000

3. Lipid Treatment Assessment Project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals;Waters;Circulation,2009

4. Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?;Saposnik;Stroke,2009

5. Missed opportunities for secondary prevention of cardiovascular disease in Canada;Hackam;Can J Cardiol,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Care Gaps and System Issues With Delivering Cardiovascular Risk Reduction and Lipid-Lowering Therapy in Secondary Prevention;Canadian Journal of Cardiology;2024-08

2. LOGAN-CV: A Prospective Study of a Multifaceted Intervention Targeting United States Clinicians to Improve Guideline-Based Management of Lipid-Lowering Therapy;Advances in Therapy;2023-11-21

3. LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals;Postgraduate Medicine;2022-10-06

4. Treatment Inertia in Patients With Familial Hypercholesterolemia;Journal of the American Heart Association;2021-07-20

5. Does management of lipid lowering differ between specialists and primary care: Insights from GOAL Canada;International Journal of Clinical Practice;2020-12-14